* Minerva Neurosciences Inc NERV.OQ reported a quarterly
adjusted loss of $1.63 per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of $1.65 per share.
* Reported revenue was zero; analysts expected zero.
* Minerva Neurosciences Inc's reported EPS for the quarter
was a
loss of $1.63.
* The mean earnings estimate of analysts had fallen by
about 8.8%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Minerva Neurosciences Inc shares had risen by 42.9% this
quarter and lost 26.2% so far this year.
* The company reported a quarterly loss of $8.72 million.
* Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $48.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 9
at 02:05 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -1.65 -1.63 Beat
Mar. 31 2022 -1.48 -1.84 Missed
Dec. 31 2021 -1.50 -4.00 Missed
Sep. 30 2021 -1.76 -1.76 Met